How to Start Rubber Glove Factory in Indonesia: PT PMA, Permits, and Cost

Decide Whether the Glove Is Medical or Nonmedical

Define the intended users and claims in a product brief before your sales team prepares packaging. Examination, surgical, household, food-handling and industrial-protection positions are not interchangeable labels. Record whether the glove is sterile, powdered or powder-free, the material and the proposed markets. A coating or material description alone does not settle the regulatory route.

The current OSS medical-rubber-goods description names medical rubber gloves under KBLI 2025 22194. The legacy 22199 nonmedical-rubber-goods description explicitly distinguishes gloves outside medical use. Check the active version, scope and project obligations rather than copying a legacy code from an old incorporation record.

Do not use a nonmedical description to sell a glove with medical claims. Equally, do not import every medical-device condition into a household-glove proposal without checking the actual product. The right comparison reduces unnecessary work while retaining the requirements that govern the intended use.

Build a Glove Budget With Separate Cost and Capital Ledgers

The first budget should show a payable setup ledger, a recurring operating ledger and a financing ledger. The AHU tariff example in the opening applies to authorized capital, not to factory investment or the price of a dipping line. For authorized capital above IDR 5 billion, the corresponding registration tariff is IDR 5,000,000. Retain the actual payment assessment and identify any other billed official items separately.

HSJGlobal’s approved PT PMA Essential reference is IDR 29,500,000 once, excluding VAT where legally chargeable , dated September 7, 2026. That benchmark covers only the specified standard entity scope, including an AHU PNBP allowance up to IDR 5,000,000. It excludes factory premises, environment and building approvals, industry or medical licensing, product registration, complex verification, banking and ongoing tax work. It is not a confirmed quote for a glove plant; a regulated or higher-risk activity requires a separately agreed scope.

VAT should be shown only under the invoicing entity’s applicable tax treatment; an excluded-VAT service reference does not prove the tax treatment of every supplier. Do not add an included government allowance a second time. Keep product-registration or laboratory fees out of a professional-fee line when they are passed through at actual cost.

For the factory total, require quotations that identify dipping-line output assumptions, utilities, commissioning, water treatment, technical services, consumables and acceptance tests. A price based only on gloves per hour can omit yield, rejects and the cost of a stable validated product. Use supplier assumptions to model cash consumption rather than publishing an unsupported universal factory-price range.

Align the PT PMA With the Dipping-Line Site

Choose the shareholders and decision authority around the actual investment. Foreign participation normally requires the PT PMA route, with the selected business field screened for admission conditions. Establish who controls the product brand, who owns manufacturing know-how and who may sign supply and quality agreements. These commercial responsibilities should be visible before documents are sent to the notary.

The company filing needs reliable investor identities, corporate authority where a company subscribes, management data and beneficial-owner information. Follow the underlying Indonesia company registration process for the entity records, then keep the medical or industrial-production workstream distinct. A company that can sign contracts is not automatically licensed to fulfil them through a glove line.

For the dipping site, ask engineering to define the material-receiving, compounding, former handling, dipping, leaching, drying, finishing and packing arrangement. Add any sterilization, outsourced processing or storage steps relevant to your product. Establish the actual water demand, wastewater composition, treatment route, heat supply and ventilation from the planned line.

Check industrial-location suitability, lawful building use and the estate’s capacity to accept the proposed discharges. Obtain written allocation of responsibilities for treatment, monitoring, utility upgrades and waste removal. If the landlord offers a common wastewater system, confirm the acceptance conditions for your effluent rather than assuming that access to the drain means the factory is covered.

A site selection decision should include access for installation and maintenance, chemical and finished-product segregation, hygiene arrangements appropriate to the product and expansion constraints. These design questions can change the licensing and quality dossier; changing the production layout after submission is more expensive than resolving it before the application.

Prepare the Medical Production and Product Evidence

For a medical-glove proposal, distinguish the facility’s production-control assessment from permission for the actual product. The OSS 22194 page lists CPAKB and domestic medical-device product authorization among supporting permissions; that list identifies possible control families, not proof that every listed permission applies to every glove. Permenkes 11/2025 provides the current health-subsector standards framework.

Use the Ministry of Health CPAKB system manual to plan the submission record. It organizes business-permit data, technical responsibility, premises or infrastructure, produced-device types, technical documents and self-assessment. Saving an application draft and having a certificate issued are different statuses.

1. Reconcile the legal company, NIB, facility coordinates and manufacturing identity used in the application.
2. Prepare the responsible technical-person information and applicable qualification evidence.
3. Connect the premises and equipment file to the actual glove types produced.
4. Upload the relevant technical evidence and complete the applicable self-assessment.
5. Preview the dossier, submit it through the live route, retain the receipt and resolve evaluator comments.
6. Confirm the issued production certificate and its scope; assess the applicable product-authorization route independently.

Build quality records that operations can maintain: approved specifications, material and supplier controls, batch identification, equipment controls, sampling and test arrangements, nonconformity handling and release responsibility. For a sterile product, the file should also address the sterilization arrangement and the evidence supporting that claim. The precise applicable technical requirements must be matched to the product; no single online checklist proves compliance for every glove family.

Control Approval Delays Without Hiding Scope Changes

Plan the programme from the first accepted project brief to a production and commercial-release decision. The entity filing, site preparation, industrial evidence and medical-quality work can progress on different tracks, but they must use matching names, addresses, capacities and product descriptions. Set internal deadlines for gathering evidence and separately record external reviewing milestones.

HSJGlobal’s general entity-registration planning reference is about two to four weeks after acceptable documents for a straightforward case. It excludes medical-manufacturing readiness, technical review, construction and product authorization. Do not multiply that reference into a factory guarantee. For the glove plant, obtain the programme from the suppliers and professional teams responsible for the actual site and dossier.

When an application is returned, identify whether the issue is identity, premises, technical responsibility, product scope or quality evidence. Fix that controlling source, then update the dependent documents. A corrected upload cannot cure an unchanged production assumption. Keep the comment, response and revised evidence linked so the next evaluator can see what was resolved.

Commercial pressure commonly appears as a request to add a new claim, change a subcontractor or launch another glove size while the application is pending. Put that change through the dossier owner before altering packaging or accepting delivery dates. A written scope decision is usually more useful than an informal assurance that all gloves are essentially the same.

The activity-based environmental screening route also needs updating when the material, throughput, water or waste assumptions change. Track those changes alongside the quality file so production improvements do not silently create a site or permit mismatch.

Choose the Glove Launch Route That Matches the Evidence

Proceed with the medical route when the intended-use statement, production controls and product-authorization requirements are supported by a consistent dossier. Proceed with a nonmedical route only where the actual product and claims fit it. The decision follows what you manufacture and claim, not which application appears faster. Hold the affected launch whenever a critical production or product condition remains unresolved.

Before committing the full factory budget, approve a cost schedule with named deliverables, invoicing periods, government and third-party treatment, tax treatment and change-order rules. Do not accept an entity-only engagement as a complete glove-production engagement. The handover should leave the company in control of both the operating evidence and the product-release records, with continuing obligations assigned to real owners.